Abstract
Fanconi anemia (FA) is a rare genetic disorder characterized by multiple congenital malformations, progressive bone marrow failure, and susceptibility to cancer. The FA-D1 subtype is associated with biallelic mutations in the breast cancer 2 genes also known as FANCD1. Patients with this mutation display severe disease phenotype. In addition, different types of cancer other than breast cancer are associated with this mutation, such as leukemia, solid tumors of the central nervous system, etc. In this review, we have surveyed the literature on FA, FA genes, their biological roles, and specifically discussed the current information available on the FA-D1 disease subtype. The observations show that the timing of biallelic loss of BRCA2 can establish the specific cancer spectrum. The knowledge about effects of the FANCD1/BRCA2 mutation on FA and cancer pathogenesis can be used for further understanding the FA-D1 subtype of the disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.